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Effects of TCDD [2,3,7,8-Tetrachlorodibenzo-PDioxin (TCDD)] on the Early Stage of Pancreatic
Carcinogenesis Induced by Azaserine in the Rat
Pancreas

Abstract: TCDD (2,3,7,8-tetrachlorodibenzo
-p-dioxin), an addictive substance in
cigarettes, has been implicated in the
pathogenesis of pancreatic carcinoma. This
compound has not been tested previously for
carcinogenicity towards the pancreas,
although TCDD is a known liver carcinogen.
The present study was designed to ascertain
whether TCDD may have a promoting effect
on the development of precursor pancreatic
lesions on the rat exocrine pancreas. For this
purpose, 30 out of a total of 60 male Leeds
rats aged two weeks received a single weekly
i.p. injection of azaserine (30 mg/kg body
weight) for 5 weeks. The rest of rats (n=30)
were used as control groups during the
injection period. At 6 weeks of age,
azaserine-initiated (n=30) and untreated
control (n=30) rats were divided into 4
groups separately each, as follows; Group: 1,
UnCt (Untreated control rats) (n=15); Group
2, AzCt (Azaserine-initiated control rats)
(n=15); Group 3, TCDD (untreated normal
rats fed TCDD, 0.038 µg/kg diet TCDD)
(n=15); Group 4, AzTCDD (Azaserine-

Introduction
Cigarette smoking is the most consistently reported
risk factor for pancreas cancer, yet the dose-response
relationship in many pancreas cancer studies is weak. In
the present experiment our purpose was to evaluate
whether a component of tobacco smoke 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) may have promoting
effects on the development of precursor lesions of rat
pancreatic carcinogenesis, although TCDD is a known
liver carcinogen.
In recent years 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) (also called dioxin) has been intensively studied
(1, 2) as the protype compound for a family of highly

initiated rats fed TCDD, 0.038 µg/kg diet
TCDD) (n=15) for 6 months. Rats were killed
and pancreata weighed and prepared for
quantitative histologic analysis of atypical
acinar cell foci (AACFs), which are putative
preneoplastic lesions. Both the number and
size of AACFs were analysed. In rats fed
TCDD, the ACFF burden was higher than in
control rats (P<0.05). TCDD feeding to rats
injected with azaserine led to a significant
increase in AACF burden over control values.
The increased size and number of acidophilic
AACF of rats fed TCDD (Group 3) and the
pancreata of AzTCDD treated rats fed TCDD
(Group 4) may indicate an enhancing effect
of TCDD. This limited experiment suggests
promoting
effects
of
2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD), but
further studies of longer term and with large
doses of TCDD are needed to allow the
assessment of whether TCDD affects growth
of azaserine induced preneoplastic pancreatic
lesions.
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toxic and structurally related chemicals known as
polyhalogenated aromatic hydrocarbons. Chemically
2,3,7,8-tetrachlorodibenzo-p-dioxin is lipophilic, almost
insoluble in water (3). Furthermore, TCDD may arise
during the heating or combustion of many
polychloronited biphenyls and is also a combinant of some
pesticides (4). It is extremely toxic, with an LD50 of
0.045 mg/kg for rats and 0.006 mg/kg for guinea pigs.
It has also been found that cigarette smoking (20/day)
induces the intake of approximately 50 µ/m3 of various
dioxins (5). It has been estimated that a typical person in
most industrialised countries ingests as much as 500
fg/kg/day (1fg=1x10-6) of TCDD (4), and
epidemiological studies indicate that a life time daily
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uptake of 100 and 1000 fg/kg/day poses a minimal
cancer hazard (6). It has been demonstrated that there is
an increased incidence of tumours at multiple sites, but
especially in the liver, in animals exposed to TCDD (7).
Although it was suggested that TCDD was a tumour
initiator (8), a study performed by Pitot (9) showed that
TCDD alone could not initiate liver foci or liver tumours in
rats. However, other studies on the mechanism of
2,3,7,8-TCDD carcinogenecity have found it also to be a
cocarcinogen (10) or a weak carcinogen (11), depending
on the animal model studied. It has been shown that two
years of skin painting in mice with TCDD resulted in
fibrosarcomas at the side of application, and it is now
considered by some to be a complete carcinogen rather
than just a promoter (12). A recent study performed on
zebrafish (Danio rerio) has shown that after TCDD
application to fish eggs, a variety of epithelial tissue and
pancreatic lesions are seen (1). There is strong evidence
that TCDD is a promoter, is not mutagenic and probably
acts through a receptor mediated mechanism (13). Any
interaction of TCDD with nucleic acids would most likely
be through the formation of a physical complex
(intercalation) rather than by direct chemical reaction
(14).
Hitherto, there has been no direct evidence of an
effect on pancreatic carcinogenesis, although its presence
in cigarette smoke makes it a candidate factor in
smoking-related pancreatic cancer. Use of the azaserinerat model to evaluate the effect of TCDD on exocrine
pancreas carcinogenesis may lead to a better
understanding of the action of this substance.
Material and Methods
Animals
Inbred male Leeds strain rats were obtained from our
breeding colony and were housed and kept five animals to
a cage under standard conditions (room temperature
23°C; lighting 7am-7pm), on sawdust bedding. A
standard diet (Paterson and Christopher Hill Group,
Porton-Rat diet PRD) and tap water were supplied ad
libitum.
Chemicals
Azaserine (98% purity), 2,3,7,8-Tetrachlorodibenzop-dioxin (TCDD) was purchased from Diverse Analyticals
Ltd, Manchester, UK, and was determined by gas
chromatography-mass spectrometry to be 99% pure.
Formalin was obtained from BDH Chemicals Limited, UK.
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Treatment
Starting at two weeks of age, 30 out of a total of 60
male Leeds rats received a single weekly i.p. injection of
azaserine (30 mg/kg body weight) for 5 weeks, dissolved
in 0.9% NaCl solution to a final concentration of 30
mg/ml on the day of injection, and untreated rats (n=30)
were used as control groups. The pups were then
returned to their respective dams and allowed to continue
suckling until 21 days of age. At 6 weeks of age,
azaserine-initiated (n=30) and untreated control (n=30)
rats were divided separately into 4 groups, as follows:
Group 1,UnCt (untreated control rats) (n=15); Group 2,
AzCt (Azaserine-initiated control rats) (n=15); Group 3,
TCDD (untreated normal rats fed TCDD, 0.038 µg/kg diet
TCDD) (n=15); Group 4, AzTCDD (Azaserine-initiated
rats fed TCDD, 0.038 µg/kg diet TCDD) (n=15). During
the experiment, control groups (Groups 1 & 2) were fed
the standard diet for 6 months after the last dose of
azaserine, while Groups 3 and 4 were fed the same diet
containing 0.038 µg/kg of 2,3,7,8-tetrachlorodibenzo-pdioxin (2,3,7,8-TCDD) for the same time. TCDD 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) was dissolved in a
minimal quantity of acetone before thorough mixing with
standard diet. All the animals were killed at 6 months
after the start of 2,3,7,8-tetrachlorodibenzo-p-dioxin
(2,3,7,8-TCDD) feeding.
Stereological analysis
At the end of 6 months the rats were sacrificed by
decapitation. The entire rat pancreas was excised at
autopsy and all adherent fat, mesentery and lymph nodes
were carefully trimmed off. The wet weight of each
pancreas was recorded before fixation in 10% buffered
neutral formalin for approximately 8-18 h. Before
immersion in the fixative solution, each pancreas was
spread out on a piece of porous paper to ensure maximal
transectional area for subsequent sectioning. Thus, a
single section of maximal area was obtained for
stereology from each pancreas. Sections were then cut at
5mm on a microtome and stained with haematoxylin and
eosin and were examined by light microscopy. Acidophilic
foci in the sections were identified and classified
according to the established criteria (15). The total area
of exocrine pancreatic tissue was measured directly in a
single histological section from each pancreas by means of
a VIDS III video image analyser (Analytical Measuring
systems, Cambridge). The same instrument was used to
count acidophilic and basophilic AACF and to measure
their transactional area. The observed data were
processed numerically by a computer software package
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(Volugen), which uses an algorithm based upon the
mathematical formula of Campbell (16), as modified by
Pugh and his co-workers (17).
Statistical analysis
Numbers of pancreatic foci, mean values and either
standard errors of means were determined for all data.
Non-parametric statistical analyses were performed by
one-way analysis of variance and the Mann-Whitney Utest.
Results
Body and Pancreas weights
All rats were healthy and thriving at the end of the
experiment. The rats fed TCDD alone (Group 3) had a
significant mean body weight increase compared with
UnCt (1) rats. The mean body weights of AzTCDD, UnCt

and AzCt rats were very similar to each other, as seen in
Table 1.
Mean pancreatic weights were markedly
increased by TCDD, both in TCDD (Group 3) and
AzTCDD rats (Group 4). The variation was statistically
significant between the TCDD (Group 3) and UnCt (Group
1) rats, but not between AzCt rats (Group 2) and
AzTCDD rats (Group 4).
Quantitative Analysis of AACF
Two phenotypically different types of atypical acinar
cell foci, basophilic and acidophilic AACF were observed
in all groups.
Basophilic AACF
The quantitative stereological data are presented in
Table 2. Quantitative analysis of tissue sections showed
that there was an enhancing effect of TCDD on basophilic
*=P<0.05

Group
No.of rats

(1) UnCt
15

(2) AzCt
15

(3) TCDD
15

(4) AzTCDD
15

Body weight
(g)

326.0±19.8

362.9±27.8

391.4±40.3
*vs UnCt

368.4±25.6

Pancreatic
weight (g)

0.700±0.131

1.298±0.163

1.230±0.179
*vs UnCt

1.362±0.192

Table 1.

Effect of 2,3,7,8-TCDD
Feeding, Following Initiation
with Azaserine, on Rat Body
and Pancreatic Weights.
(Mean Value±Standard Error
of Mean)

Table 2.

Effect of 2,3,7,8-TCDD
Feeding, Following Initiation
with Azaserine, on Induction
of Pancreatic Basophilic
Atypical Acinar Cell Foci
(AACF).
(Mean
values±Standard Error of
Mean)

Abbreviations
UnCt
: Untreated control rats
AzCt
: Azaserine-initiated control rats
TCDD
: Untreated rats fed only TCDD
AzTCDD : Azaserine-initiated TCDD fed rats

*=P<0.05
Group
No.of rats

(1) UnCt
15

(2) AzCt
15

(3) TCDD
15

(4) AzTCDD
15

No. of AACF
per pancreas

0.57±1.82

282.17±120.07

7.17±14.15
*vs UnCt

318.72±163.91
*vs AzCt

Volume of
AACF as
%of pancreas

0.002±0.006

0.144±0.78

0.002±0.005

0.185±0.123

Mean focal
diameter (mm)

0.23±0.423

0.30±0.04

0.25±0.03

0.24±0.085

Mean focal
volume (mm3)

0.003±0.021

0.068±0.0058

0.0044±0.0014

0.0106±0.0117
*vs AzCt
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AACF incidence. At six months, AzTCDD rats exhibited a
significantly increased abundance of basophilic AACF
compared to AzCt rats, reflected in the number of AACF
per pancreas (318.72 vs 282.17) and mean focal volume
(0.0068 vs 0.0106). In addition, the number of AACF
per pancreas in rats fed TCDD was significantly higher
than in UnCt animals.
Acidophilic AACF
As shown Table 3, azaserine initiated rats fed TCDD
had a higher number of AACF per pancreas (98.02 vs
117.94), and volume of AACF as % of pancreas (0.741
vs 1.306) than AzCt rats, and the differences were
significant (P<0.05) between the two groups. There was
a statistically significant increase in most of the
quantitative stereological parameters of acidophilic AACF
in the exocrine pancreas of TCDD rats compared with
UnCt rats. The differences were statistically significant
(P<0.05) except for the mean focal diameter of AACF.
Discussion
The body and pancreatic weights of rats fed TCDD
without azaserine initiation were significantly increased in
this study, in contrast to previous reports (17). It has
been suggested that TCDD may induce multiple
endocrine-mediated metabolic alterations (18). In a
previous study it was suggested that body weight loss in
TCDD-induced rats could be attributed to a decrease in
pancreatic insulin secretion, since this was not assayed.
However, it seems that the body weight changes in rats
fed TCDD may be related to hormone release. It has been

shown that TCDD-induced somatostatin levels coincided
with an increase in the body weight of rats (19), which
suggests that TCDD administration may alter pancreatic
function and weight. TCDD is known to produce hepatic
tumours in rats (20, 21). However, TCDD has little if any
mutagenic activity and does not bind appreciably to DNA
in vivo (22). It has been suggested, therefore, that this
compound is not a complete carcinogen, but rather that it
acts as a tumour promoter, enhancing neoplastic
expression in already initiated cells (9). A recently work
suggests that the pathological changes induced by TCDD
in the liver and thymus are mediated entirely by aryl
hydrocarbon receptor (AhR) (23). Kociba (24) found
that TCDD at the dose range of 0.07-0.1 µ/kg/day elicited
a positive carcinogenic response in rats. An intermediate
dose range of 0.007-0.01 µ/kg/day elicited a less than
definitive carcinogenic response in his studies. In this
study, the quantitative stereological analysis of basophilic
AACF showed that the number of AACF per pancreas was
significantly higher in rats fed only TCDD. This suggests
that TCDD enhances the development of basophilic foci.
However, this type of acidophilic foci is not generally
considered to be of great importance in pancreatic
carcinogenesis (15). The present findings suggest that in
azaserine initiated rats TCDD seems to promote the
growth of basophilic foci more strongly than does TCDD
fed alone. In this investigation, the number of AACF per
pancreas and mean focal volume of basophilic foci were
significantly higher in AzTCDD rats than in AzCt animals.
Basophilic AACF seems to have only a low potential
for growth and progression to neoplasm, whereas a
higher fraction of lesions that are classified as acidophilic

*=P<0.05
Group
No.of rats

(1) UnCt
15

(2) AzCt
15

(3) TCDD
15

(4) AzTCDD
15

No. of AACF
per pancreas

0.55±1.52

98.02±48.01

12.94±13.83
*vs UnCt

117.94±66.049
*vs AzCt

Volume of
AACF as
%of pancreas

0.005±0.019

0.741±0.511

0.049±0.424
*vs UnCt

1.306±1.082
*vs AzCt

Mean focal
diameter (mm)

0.71±0.81

0.60±0.08

0.426±0.256

0.64±0.082

Mean focal
volume (mm3)

0.011±0.003

0.143±0.136

0.044±0.038
*vs UnCt

0.147±0.073
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Table 3.

Effect of 2,3,7,8-TCDD
Feeding, Following Initiation
with Azaserine, on Induction
of Pancreatic Acidophilic
Atypical Acinar Cell Foci
(AACF)
(Mean
values±Standard Error of
Mean)
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seem to have the potential for such progression. The
results of present study indicate an enhancing effect of
TCDD in azaserine initiated rats. The number of AACF per
pancreas, volume of AACF as % of pancreas and mean
focal volume were significantly higher in AzTCDD rats
than in the AzCt group. Furthermore, the number of
AACF per pancreas, volume of AACF as % of pancreas
and mean focal volume quantitative parameters were
higher in TCDD rats than in the UnCt group. This
suggests that TCDD is a significant factor in the
promotion of pancreatic AACF during the post-initiation
stage in azaserine initiated rats. The observed increase in
the quantitative parameters of the acidophilic AACF of
AzTCDD rats in the present study may indicate that there
is an effective increase in the incidence of foci in the early
stage. Long-term studies conducted on TCDD in mice and
rats have shown higher dosages to be associated with an
increase in hepatocellular tumours (12, 24). The data
reported here are consistent with a promoting effect of
TCDD on azaserine-induced pancreatic carcinogenesis. So
far the carcinogenic effects of TCDD on the exocrine
pancreas have not been sufficiently evaluated to permit us

to interpret the present limited findings as indicative of a
potential carcinogenic effect. However, the results of
present study show that the low level of TCDD (close to
environmental levels) is associated with an increased
acidophilic AACF incidence. Since the dosage of TCDD
used was very low, this result indicates the need for
further studies in this area. The data obtained from the
present experiment only support the view that TCDD may
promote azaserine induced carcinogenesis in the
pancreas; however, more exposure and time is necessary
for a definitive conclusion. Thus, TCDD remains a
plausible candidate as a causative factor in smokingrelated pancreatic cancer.
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